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Abstract
Staphylococcus aureus necrotizing pneumonia is a severe disease caused by S. aureus strains carrying the Panton Valentine
leukocidin (PVL) genes (lukS-PV & lukF-PV) encoded on various bacteriophages (such as phiSLT). Clinical PVL+ strains isolated
from necrotizing pneumonia display an increased attachment to matrix molecules (type I and IV collagens and laminin), a
phenotype that could play a role in bacterial adhesion to damaged airway epithelium during the early stages of necrotizing
pneumonia (J Infect Dis 2004; 190: 1506–15). To investigate the basis of the observed adhesion of S. aureus PVL+ strains, we
compared the ability of PVL+ and their isogenic PVL2 strains to attach to various immobilized matrix molecules. The
expression of recombinant fragments of the PVL subunits and the addition of synthetic peptides indicated that the
processed LukS-PV signal peptide (LukS-PV SP) was sufficient to significantly enhance the ability of S. aureus to attach to
extracellular matrix (ECM) components. Furthermore, we showed that adhesion to ECM components was inhibited by
heparin and heparan sulfates (HS) suggesting that in vivo, HS could function as a molecular bridge between the matrix and
S. aureus expressing the LukS-PV signal peptide. Site directed mutagenesis, biochemical and structural analyses of the LukS-
PV signal peptide indicate that this peptide is present at the S. aureus surface, binds to HS in solid phase assay, and mediates
the enhanced S. aureus matrix component adhesion. Our data suggests that after its cleavage by signal peptidase, the signal
peptide is released from the membrane and associates to the cell wall through its unique C-terminus sequence, while its
highly positively charged N-terminus is exposed on the bacterial surface, allowing its interaction with extracellular matrix-
associated HS. This mechanism may provide a molecular bridge that enhances the attachment of the S. aureus PVL+ strains
to ECM components exposed at damaged epithelial sites.
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Introduction
Panton-Valentine leukocidin (PVL) is a two-component (LukS-
PV and LukF-PV), hetero-oligomeric pore-forming toxin which
prevalence in S. aureus isolates used to be low (ca. 2%) but is
currently increasing due to the worldwide diffusion of PVL-
producing methicillin-resistant S. aureus (MRSA) strains [1]. PVL is
associated with staphylococcal strains that cause deep skin and soft
tissue infections as well as severe necrotizing pneumonia [2].
Necrotizing pneumonia affects children and young adults (median
age 15 years) [3], is often preceded by a viral-like illness, and is
characterized as a rapidly expansive pneumonia, associated with
haemoptysis, leukopenia and pleural effusion that can progress
towards acute respiratory distress syndrome [3,4]. Lung tissues
from staphylococcal necrotizing pneumonia patients revealed
that respiratory epithelium ulcerations that extend from the
larynx to the lobar bronchi were heavily colonized with abundant
Gram-positive cocci [3]. In vitro, PVL+ clinical isolates from
necrotizing pneumonia display an increased adhesion to extracel-
lular matrix molecules (ECM) present in epithelial basement
membranes and in the subjacent connective tissue such as collagen
I, IV and laminin [5]. The enhanced attachment to damaged
airway epithelium could play a central role during bacterial
colonization and the early stages of infection.
To investigate the basis of the observed increased adhesion of S.
aureus PVL+ strains, we compared the ability of isogenic PVL+ and
PVL2 strains to attach to various immobilized matrix molecules.
The expression of fragments of the PVL subunits, along with the
addition of synthetic peptides indicated that the LukS-PV signal
peptide (LukS-PV SP) is sufficient to significantly enhance the
ability of S. aureus to attach to matrix components. Moreover, we
show here that adhesion to ECM components is efficiently
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inhibited by heparin/heparan sulfates (HS) suggesting that in vivo,
HS could function as bridges between S. aureus expressing the
LukS-PV signal peptide and ECM components exposed after
epithelium damage. The biochemical properties of the LukS-PV
signal peptide indicate that it could be released outside the
cytoplasmic membrane after signal peptidase cleavage, which was
confirmed by the use of antibodies directed against an histidine-
tagged LukS-PV signal peptide. Site directed mutagenesis of the
LukS-PV signal peptide supports the hypothesis that the C-
terminus of the signal peptide is associated to the bacterial cell wall
and the N-terminus, which is highly positively charged, binds to
matrix-associated heparan sulfates.
Results
Expression of the luk-PV operon increases the adhesion
of S. aureus and Lactococcus lactis to various ECM
proteins
To determine if the enhanced attachment of the clinical PVL-
positive isolates to ECM proteins was mediated by gene products
encoded by the phage that carries PVL (phiSLT), by PVL itself, or
by other genes present in the S. aureus chromosome, we
constructed a series of isogenic strains lysogenizing the phage
phiSLT into several PVL negative clinical isolates. We also
included isogenic strains made by allelic replacement of the luk-PV
genes (lukS-PV and lukF-PV) in PVL positive strains. All these
strains were tested for their ability to attach to various immobilized
extracellular matrix proteins: collagen IV and laminin, represent-
ing basement membrane components, and collagens V, I and
elastin, all present in the subjacent lung connective tissue (Figure 1).
Compared to the PVL negative strains (RN6390, clinical 1, 2 and
3) the lysogenized strains (RN6390 phiSLT, clinical 1, 2 and 3
phiSLT) displayed a significantly higher (.6 fold) adhesion to all
the ECM components tested, with a level of adhesion similar to
those mediated by MSCRAMMs [6]. Similarly, compared to the
natural PVL+ strains MW2 and LAC, the delta-luk-PV derivatives
(MW2DPVL, LACDPVL) adhered poorly to ECM proteins. Thus,
the enhanced attachment phenotype previously observed in non-
isogenic clinical isolates, was confirmed to be associated with the
expression of an intact PVL operon. To confirm this hypothesis,
we transformed S. aureus RN6390 with a plasmid expressing the
luk-PV operon in trans (Luk-PV plasmid) and tested the ability of
the resulting strain to attach to ECM proteins. The results revealed
that the luk-PV operon was sufficient to confer S. aureus the
enhanced adhesion to ECM proteins (Figure 1). To test if this
property could be transferred in an heterologous host, the Luk-PV
plasmid was introduced into Lactococcus lactis; indeed, the resulting
strains showed enhanced adhesion similar to that of all strains of S.
aureus expressing an intact PVL.
The LukS-PV signal peptide mediates the enhanced
attachment (Figure 2)
To establish which gene of the luk-PV operon (lukS-PV or lukF-
PV) was required to induce this phenotype, lukS-PV and lukF-PV
genes were cloned and expressed independently in S. aureus
RN6390 delta-spa (LUG960); this strain was chosen to avoid any
possible effects mediated by an increased transcription of Spa [7].
Compared to the parental strain (LUG960), or to the strain
expressing the plasmid with no insert (no insert plasmid), the
expression of LukS-PV alone (LukS-PV plasmid) resulted in
enhanced adhesion phenotype similar to that induced by the
complete operon (Luk-PV plasmid) (Figure 2). In contrast,
expression of LukF-PV alone did not result in a significant
enhanced adhesion phenotype. A major chromosomal deletion of
the luk-PV operon in LUG960 preserving the 41 N-terminal
amino acids of pre-mature LukS-PV and 128 C-terminal amino
acids of LukF-PV (chromosomal partial DPVL) showed an
attachment phenotype similar to the strain that carries an intact
luk-PV operon (Figure 2). We thus cloned and expressed either the
41 N-terminal aa of pre-mature LukS-PV or the 128 C-terminal
Figure 1. Binding capacity of isogenic strains from various genetic backgrounds to ECM components. Isogenic strains of Staphylococcus
aureus and Lactococcus lactis examined for their binding capacity (Y-axis, absorbance reading at 540 nm) to ECM proteins (Sigma) coated on 96-well
plates, at concentrations of 5 mg/mL (identical results were obtained at concentrations of 50 mg/mL). Collagen I (white bars); collagen IV (grey bars);
collagen V (dark grey bars); elastin (black bars), laminin (dotted bars). RN6390, ref agr1 strain, luk-PV negative; RN6390phiSLT, RN6390 lysogenized
with phiSLT; RN6390 Luk-PV plasmid, RN6390 carrying a luk-PV plasmid; MW2DPVL, MW2 deleted of the luk-PV operon; MW2 wild type (luk-PV
positive); LACDPVL, LAC deleted of the luk-PV operon; LAC, LAC wild type (luk-PV positive); clinical1, luk-PV negative clinical strain from gut;
clinical1phiSLT, clinical 1 lysogenized with phiSLT; clinical2, luk-PV negative clinical strain from furuncle; clinical2phiSLT, clinical2 lysogenized with
phiSLT; clinical3, luk-PV negative clinical strain from pneumonia; clinical3phiSLT, clinical3 lysogenized with phiSLT; Lactococcus lactis, L. lactis ;
Lactococcus lactis Luk-PV plasmid, L. lactis carrying a luk-PV plasmid. The vertical lines indicate the standard deviations.
doi:10.1371/journal.pone.0005042.g001
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amino acids of LukF-PV in LUG960 cells under the control of the
P-luk-PV promoter. Compared to the parental strain, the strain
expressing the first 41 amino acids of pre-mature LukS-PV showed
an enhanced adhesion phenotype similar to that of the strain
expressing the intact Luk-PV operon. In contrast, the strain
expressing the 128 C-terminal amino acids of LukF-PV had no
effect on adhesion. Further subcloning revealed that the sequence
encoding the 28 amino acids signal peptide of LukS-PV (LukS-PV
SP) was sufficient to mediate enhanced bacterial attachment to
ECM components. Conversely, the strain LukS-PV DSP express-
ing mature LukS-PV devoid of its signal peptide showed a basal
level of attachment, similar to that shown by a strain carrying the
vector without insert. To rule out the possibility that the mRNA
encoding the LukS-PV signal peptide but not the signal peptide
itself was involved, a construct expressing luk-PV mRNA devoid of
its start codon was expressed in LUG960 (a control RT-PCR
experiment revealed that the construct produced the correspond-
ing mRNA, data not shown). This luk-PV mRNA construct did not
increase attachment to ECM proteins. These data confirms that
the expression of the 28 amino acids constituting the LukS-PV
signal peptide mediate the enhanced attachment phenotype.
The enhanced attachment phenotype is specific to the
LukS-PV signal peptide (Figure 2)
To determine if the phenotype observed with LukS-PV signal
peptide could be a general property of other staphylococcal signal
peptides, we expressed the LukF-PV signal peptide, the TSST-1
signal peptide (unrelated to Luk-PV SP), the LukE signal peptide
(64% similarity to LukS-PV signal peptide) and the LukD signal
peptide (unrelated to LukS-PV and 87% similarity to LukF-PV
signal peptide) under the control of the luk-PV promoter. Figure 2
showed that only the expression of LukS-PV signal peptide can
mediate the enhanced bacterial attachment to ECM proteins. A
similar enhanced attachment to ECM proteins was obtained when
expressing the full-length LukS-PV, LukS-PV signal peptide in
Lactococcus lactis, and not when expressing LukE signal peptide
(data not shown).
Adhesion to matrix proteins could be mediated by
heparan sulfates (HS)
Since the various ECM proteins tested in the present work
yielded similar results, a possible common mechanism was sought.
We reasoned that it would be unlikely to find a common structural
motif among all tested ECM proteins (collagens, laminins and
elastin) that could serve as a ligand for the LukS-PV-signal
peptide-expressing strains. However, we hypothesized that he-
paran sulfates (HS) could be the ligand of the LukS-PV signal
peptide-expressing strain, since HS are known to bind several
ECM proteins and could be present in trace amount in
commercially available purified preparations of ECM proteins
(Sigma-Aldrich technical service does not guarantee their ECM
preparations as free of heparan sulfates). Due to their high
negative charge, HS chains interact with a multitude of proteins,
including growth factors/morphogens and their receptors, che-
mokines, and extracellular-matrix proteins [8]. To test this
hypothesis, we used heparin and heparan sulfates (HS) as soluble
Figure 2. Binding capacity of isogenic strains to ECM components. Isogenic strains of Staphylococcus aureus examined for their binding
capacity (Y-axis, absorbance reading at 540 nm) to collagen IV (Sigma) coated on 96-well plates, at concentrations of 5 mg/mL (identical results were
obtained at concentrations of 50 mg/mL). Collagen I (white bars); collagen IV (grey bars); collagen V (dark grey bars); elastin (black bars), laminin
(dotted bars). Parental (LUG960) indicates the genetic background in which all genetic modifications were made as follows: no insert plasmid,
plasmid vector with no insert; phiSLT, lysogenization with phiSLT; Luk-PV plasmid, plasmid encoding for lukS-PV and lukF-PV; LukS-PV plasmid,
plasmid encoding for lukS-PV; LukF-PV, plasmid encoding lukF-PV; chromosomal partial DPVL, partial deletion of the chromosomal luk-PV operon;
41aa Nterm LukS-PV, plasmid encoding for the first 41 amino acids of premature LukS-PV; 128aa Cterm LukF-PV, plasmid encoding for the last 128
amino acids of premature LukF-PV; LukS-PV SP, plasmid encoding the LukS-PV signal peptide; LukS-PV DSP, plasmid encoding LukS-PV without signal
peptide; luk-PV mRNA, plasmid encoding for the luk-PV operon mRNA devoid of start codon; LukF-PV SP, plasmid encoding the LukF-PV signal
peptide; TSST-1 SP, plasmid encoding the TSST-1 signal peptide; LukE-SP, plasmid encoding for the LukE signal peptide; LukD-SP; plasmid encoding
for the LukD signal peptide. The vertical lines indicate the standard deviation.
doi:10.1371/journal.pone.0005042.g002
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competitors in the immobilized ECM adhesion assay. Preincuba-
tion of the bacteria with increasing concentrations of HS reduced
the adhesion to all matrix molecules tested (Figure 3A and Figure
S1). Similar results were obtained when using heparin instead of
heparan sulfates (data not shown). However, preincubation of the
various matrix proteins with HS prior to the addition of bacteria
did not alter the bacterial adhesive properties, nor did the
preincubation of bacteria with matrix proteins followed by the
addition of HS (Figure 3B). When increasing concentrations (X-
axis) of heparinase III was added to the matrix protein prior to the
adhesion assay, the bacterial adhesion decreased in a dose-
dependent manner (Figure 4). In a converse experiment, we used
collagen I and V from distinct sources. Collagen I was extracted
from bovine bones using pepsin and recombinant V was produced
in the human embryonic kidney cell line (293-HEK) cells (see
Material and Methods). These preparations are thought to be both
devoid of linked heparan sulfates. A strain expressing LukS-PV
signal peptide did not show enhanced adhesion to collagens I and
V purified in our laboratory, while it did when using collagen I
and V purchased from Sigma (Figure 5). Interestingly, preincu-
bation of the in-house preparations of collagen I and V with
heparan sulfates, followed by the addition of bacteria, enhanced
the staphylococcal adhesion to both substrates (Figure 6).
Collagens I and V are known to contain a heparin binding site
[9,10] and are good candidates for HS-mediated cell interactions.
Taken together, these data suggest that the ligand of LukS-PV
signal peptide-expressing strains are heparan sulfates.
Validation of the interaction between LukS-PV signal
peptide and HS
To determine the HS binding ability of the LukS-PV signal
peptide, we used a solid phase assay, where the reducing end of
biotinylated HS was captured on a streptavidin coated sensorchip.
This system mimics, to some extent, the cell surface- or the
extracellular matrix-anchored proteoglycans. Surface plasmon
Figure 3. Inhibition of adhesion to collagen IV by heparan sulfates. Isogenic strains of Staphylococcus aureus examined for their binding
capacity (Y-axis, absorbance reading at 540 nm) to collagen IV (Sigma) coated on 96-well plates, at concentrations of 5 mg/mL. Heparan sulfates were
added at decreasing concentrations (X-axis) to the bacteria before the adhesion assay (panel A), or after the preincubation of the bacteria with
collagen IV (Sigma) (panel B). Parental (LUG960) indicates the genetic background in which the genetic modifications were made; LukS-PV SP,
parental carrying a plasmid encoding the LukS-PV signal peptide. The vertical lines indicate the standard deviation.
doi:10.1371/journal.pone.0005042.g003
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resonance (SPR) real time monitoring was performed to measure
changes in refractive index of the chip after the binding of the
peptide to the immobilized HS. Injection of a range of concentra-
tions of LukS-PV signal peptide over the HS-coated sensorchip is
represented by the binding curves shown in Figure 7, whereas similar
injections over a control surface (containing streptavidin only) did
not lead to significant signal (data not shown), demonstrating the
existence of an interaction between the polysaccharide and the
peptide. Analysis of these sensorgrams, using a simple A+B=AB
model (single binding site model), indicates an affinity in the low mM
range (Kd=5.662.2 mM). Presumably, at the bacterial surface, the
multiplicity of the LukS-PV signal peptide should strongly contribute
to avidity, resulting in tighter interactions.
Extracellular LukS-PV SP mediates bacterial attachment
To test if the attachment of the LukS-PV signal peptide-
expressing strain was mediated by cell-surface-associated materi-
als, extracellular detergent extracts of the LukS-PV signal peptide-
expressing (donor) strain were prepared using either 2% SDS
(sodium dodecylsulfate), 2% DPC (dodecylphosphocholine), or 2%
DM (dodecylmaltoside). These extracts were then added to
LUG960 (recipient) cells; the treated bacteria were then tested
for their capacity to adhere to collagen IV from commercial source
(Sigma-Aldrich). Incubation of the 2% SDS extracellular extract
from the donor strain with the recipient strain resulted in
enhanced adhesion to collagen IV (Figure 8). In addition, the
addition of extracellular extracts obtained with mild detergents
Figure 4. Inhibition of adhesion to collagen IV by heparinase. Isogenic strains of Staphylococcus aureus examined for their binding capacity
(Y-axis, absorbance reading at 540 nm) to collagen IV (Sigma) coated on 96-well plates, at concentrations of 5 mg/mL. Heparinase III was added at
increasing concentrations (X-axis) to collagen IV (Sigma) before the adhesion assay. Parental (LUG960) indicates the genetic background in which the
genetic modifications were made; LukS-PV SP, parental carrying a plasmid encoding the LukS-PV signal peptide. The vertical lines indicate the
standard deviations.
doi:10.1371/journal.pone.0005042.g004
Figure 5. Binding capacity of isogenic strains to collagens V and I from distinct sources. Isogenic strains examined for their binding
capacity (Y-axis, absorbance reading at 540 nm) to collagens I and V (Sigma) versus in-house preparation of collagens I and V coated on 96-well
plates, at concentrations of 5 mg/mL. Parental (LUG960) indicates the genetic background in which the genetic modifications were made; LukS-PV SP,
parental carrying a plasmid encoding the LukS-PV signal peptide. The vertical lines indicate the standard deviations.
doi:10.1371/journal.pone.0005042.g005
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Figure 6. Binding capacity of isogenic strains to in-house collagens V and I after addition of increasing concentrations of heparan
sulfates. Isogenic strains examined for their binding capacity (Y-axis, absorbance reading at 540 nm) to collagens I and V preparations from our
laboratory coated on 96-well plates, at concentrations of 5 mg/mL. Before the adhesion assay, heparan sulfates were added at increasing
concentrations (X-axis) to the plates coated with recombinant collagen V (panel A) or highly purified collagen I (panel B). Parental (LUG960) indicates
the genetic background in which the genetic modifications were made; LukS-PV SP, parental carrying a plasmid encoding the LukS-PV signal peptide.
The vertical lines indicate the standard deviations.
doi:10.1371/journal.pone.0005042.g006
Figure 7. The LukS-PV signal peptide binds to heparan sulfates in a solid phase assay. Overlay of sensorgrams obtained when LukS-PV
signal peptide at (from top to bottom) 45, 30, 20, 13.3 and 8.9 mg/ml was injected for 5 minutes at 50 ml/min over a HS activated sensorchip. The
Binding response (in RU) was recorded as a function of time (in s).
doi:10.1371/journal.pone.0005042.g007
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(DM or DPC) to the recipient cells resulted in a modest enhanced
adhesion (Figure 8). Conversely, no increased adhesion was
observed when using extracellular cell extracts (regardless of the
detergent used) from LUG960 used as donor cells (Figure 8).
These data indicate that a SDS soluble compound present at the
surface of LukS-PV positive strains is able to confer the enhanced
adhesion phenotype. To determine if the LukS-PV SP was present
in this extract, a 2% SDS extract was prepared from an S. aureus
strain expressing an His-tag LukS-PV signal peptide fusion or a
His-tag LukS-PV fusion. Western blot analysis performed using an
anti-His-tag antibody showed in both extracts a band of the
expected size (approximately 3 kDa) (Figure 9), demonstrating that
the signal peptide was present in the SDS extracts. This Figure also
shows that unprocessed His-tagged LukS-PV was not detected in
the western blot, demonstrating the efficiency of the signal peptide
processing. In addition, control experiments revealed that the
secretory function of the signal peptide was not impaired by the
His-tag, since the mature LukS-PV component of the PVL was
detected by ELISA in the bacterial supernatant (Table S1).
To test whether the signal peptide could on its own enhance
bacterial attachment, synthetic peptides corresponding to LukS-
PV signal peptide, LukF-PV signal peptide, and a scrambled
version of the LukS-PV signal peptide were added to the parental
bacterial strain (LUG960) in the microtiter adhesion assay.
External addition of the synthetic LukS-PV signal peptide, but
not the synthetic LukF-PV signal peptide nor the scrambled LukS-
PV signal peptide resulted in a dose-dependent enhanced adhesion
(Figure 10 A). This reveals that the signal peptide of LukS-PV
contributes to the enhanced adhesion phenotype of PVL-positive
strains. Enhanced adhesion was observed only at synthetic peptide
concentrations above 500 mg/ml; however, when a 2% SDS
extract was prepared from non-adhering bacterial cells plus the
synthetic peptide, the resulting preparation conferred increased
adhesion at lower synthetic peptide concentrations (Figure 10B).
This suggests that the concomitant presence of an unknown cell-
wall component with the synthetic signal peptide is required in
order to confer the full adhesion phenotype. However, we cannot
exclude that some post-translational modification may occur in the
physiological situation, thus explaining why the synthetic peptide
remains less efficient to restore adhesion than that produced in vivo.
Conformational analysis of LukS-PV SP and LukF-PV SP by
circular dichroism (CD)
To gain insight into the structure and lipotropic properties of
the LukS-PV and LukF-PV signal peptides, the solubility and
conformation of the corresponding purified synthetic peptides
were examined under various stabilizing conditions by using either
cosolvents (TFE: water mixtures, SDS) that are very useful tools
for probing the propensity of peptides for secondary structure
formation ([11,12], and references therein), or membrane mimetic
Figure 8. Adherence is mediated by cell wall associated material. Following overnight culture and centrifugation, the bacterial pellet of the
donor strain (parental or parental carrying a plasmid expressing LukS-PV signal peptide) was resuspended in 1 mL extraction buffer (2% SDS or DM or
DPC), heated (or not) at 95uC for 2 min, and centrifuged. The supernatants were used to resuspend the bacterial pellet of the recipient strain to be
tested (parental) in the adherence assay to type IV collagen (5 mg/mL, Sigma) coated on 96-well plates. The first two lanes are control strains (parental
and parental expressing LukS-PV signal peptide) with no cell extract added. All other lanes indicate the various conditions of cell extracts added to
the parental. The vertical lines indicate the standard deviations.
doi:10.1371/journal.pone.0005042.g008
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media including lysolipid (lysophosphatidyl choline, LPC), and
detergents (DM, LPC and DPC). As is expected, both LukS-PV
and LukF-PV signal peptides solubilized in SDS exhibited the
typical spectra of a-helix folding, with two minima at 208 and
222 nm and a maximum at 192 nm (Figure 11 A–B, cyan curve).
TFE is known to solubilize hydrophobic peptides as monomers
and to stabilize the folding of peptidic sequences with an intrinsic
propensity to adopt an a-helical structure. Dissolving both
peptides in 50% TFE generated spectra that were typical of a-
helical folding, and similar in intensity to that obtained in SDS
(Figure 11 A–B, magenta curve). Various CD deconvolution
methods used indicate a predominant a-helix content ranging
from 64 to 77% in SDS and in TFE 50% for LukS-PV signal
peptide, but only of about 40% for LukF-PV signal peptide in both
media. In LPC (Figure 11 B, green curve) and DM (Figure 11 B,
red curve), the latter peptide exhibited CD spectra that are similar
of ß-sheet-like conformation with a maximum around 190 nm and
a minimum around 215 nm, while the shape of CD spectrum
recorded in DPC (Figure 11 B, blue curve) suggested a mixture of
a-helix and ß-sheet like conformation. In addition, the LukF-PV
signal peptide was poorly soluble in water and exhibited a ß-sheet-
like conformation indicating of soluble, micelle-like aggregates
(Figure 11B, black line). In addition, the LukF-PV signal peptide
aggregates over time in the absence of a hydrophobic, membrane-
like environment. These findings are consistent with the computer
prediction that this peptide could easily aggregate (score of 0.8
with Zyggregator [13]). In contrast, the LukS-PV signal peptide is
largely soluble in water, does not exhibit the propensity to
aggregate (in keeping with a score of 20.1 with Zyggregator), and
exhibits a typical random coil CD spectrum, with a single negative
peak at 198 nm (Figure 11A, black line). When studied by NMR,
the LukS-PV signal peptide 1D spectrum displays fine and well-
resolved signals, indicating that the peptide exists as a monomer in
water (data not shown). Moreover, it only partly folds into a-helix
in the presence of membrane mimetics (LPC, DPC and DM,
Figure 11A). These analyses suggest that the LukS-PV signal
peptide has little propensity to bind to the membrane hydrophobic
core. Taken together, these analyses indicate that after its
processing by the signal peptidase, the LukS-PV signal peptide
could readily leave the membrane translocon context and
incorporate to the cytosolic or the extracellular aqueous
environment.
Identification of LukS-PV signal peptide residues involved
in the adhesion phenotype using mutagenesis
The above data favor a model in which the LukS-PV signal
peptide after cleavage by the signal peptidase is released outside
the cytoplasmic membrane but remains associated to the cell
surface and confers adhesion to heparan sulfates. Given the amino
acid composition of the peptide and the homologies with other
signal peptides that do not confer increased adhesion (especially
LukE signal peptide which is the most closely related), we
hypothesized that the C-terminus of LukS-PV signal peptide
could be bound to the cell wall and the highly positively charged
N-terminus could bind to negatively charged heparan sulfates. To
test this hypothesis, a series of deletions and point mutations of the
LukS-PV signal peptide were constructed, as well as chimeras
combining portions of LukS-PV signal peptide and LukE signal
peptide.
On the N-terminus, a single residue substitution that replaced a
positively charged residue with another one (R5K) did not alter the
adhesion property of the resulting peptide. In contrast, replacing
positively charged residue with neutral one (K4N) significantly
reduced adhesion to collagen IV, whilst the double substitutions
K4N/K5A and K3A/K4N reduced the adhesion even more
(Figure 12). These data highlight the strict requirement of three
positives charges on the N-terminus for efficient adhesion.
A LukS-PV signal peptide deletion mutant in which the last 6
(1–22) or only 3 (1–25) C-terminal residues were removed,
completely abolished the adhesion property of the peptide-
expressing strains, revealing that a full-length C-terminus is
required for adhesion. Single amino acid substitutions of the
LukS-PV peptide C-terminus with residues biochemically similar
to those present in the LukE signal peptide (S22P or H24Q) or
with residues of different charge properties (H24A, E25Q or
K27A) did not abolish adhesion. Finally, a strain expressing a
chimera composed of the N-terminal half of the LukE signal
peptide fused to the C-terminal half of LukS-PV signal peptide
exhibited the full adhesion phenotype, whilst the reverse chimera
(LukS-PV SP::LukE SP) did not enhance adhesion (Figure 12). To
ensure that the modified peptides properly function as signal
peptides, several of the above-described mutated peptides were
expressed in fusion with the LukS-PV component of PVL that they
were supposed to secrete. Quantification of LukS-PV in the
supernatant confirmed that the selected mutations in the signal
peptide did not affect the efficiency of the secretion machinery.
Conversely, when LukS-PV PVL was expressed without signal
peptide, only residual amount of LukS-PV was detected in the
supernatant (Table S1). Altogether, these data indicate that the
Figure 9. The signal peptide is present in cell wall associated
material. The 2% SDS extract of various strains were run on 17% SDS
PAGE, transferred to nylon membrane and probed with mouse
monoclonal anti-poly His antibody (1:500) (Sigma) followed by goat
anti mouse HRP conjugated antibody (1:2000) (Sigma). Parental
(LUG960) indicates the genetic background in which the genetic
modifications were made; His-LukS-PV SP, parental carrying a plasmid
encoding the His-tagged LukS-PV signal peptide alone; His-LukS-PV,
parental carrying a plasmid encoding the His-tagged full length LukS-
PV.
doi:10.1371/journal.pone.0005042.g009
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positively charged amino acid cluster of the N-term interacts with
heparan sulfates and that a stretch of C-terminal residues unique
to the LukS-PV-signal peptide (TSFHESKA) likely constitute an
important determinant for the peptide association to the bacterial
cell wall. This C-terminal sequence can tolerate single amino acid
substitutions, suggesting the existence of a rather wide binding
region for interaction with cell wall components.
Discussion
Clinical PVL+ S. aureus isolates have been reported to display an
enhanced attachment to ECM proteins (type I collagen, type IV
collagen, and laminin) that are abundant in the lung [5]. During
the early stages of infection, ECM proteins from the epithelial
basement membrane and the adjacent connective tissue are
Figure 10. Effect of the addition of synthetic signal peptide on the adherence capacity of the parental strain. A. Increasing
concentrations of synthetic LukS-PV signal peptide, LukF-PV signal peptide and scrambled synthetic LukS-PV signal peptide were added to parental
cells (LUG960); the mixtures were then tested for adhesion to type IV collagen (Sigma, 5 mg/mL) coated on 96-well plates. The vertical lines indicate
the standard deviations. B. Increasing concentrations of synthetic LukS-PV signal peptide was added to the 2% SDS extract of the parental strain
(white bars, SP+SDS extract) or to the parental strain before 2% SDS extraction (black bars, (SP+Bacteria) SDS extract); in both cases the mixture was
used to resuspend the bacterial pellet of the recipient strain (parental) in the adherence assay to type IV collagen (5 mg/mL, Sigma) coated on 96-well
plates.
doi:10.1371/journal.pone.0005042.g010
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exposed to damaged epithelium sites. The results obtained with
various isogenic strains made in various genetic backgrounds
including an heterologous host (Lactococcus lactis) confirmed that
PVL-positive strains have enhanced attachment to the ECM
components, the actual target being heparan sulfates and not
directly ECM proteins. Cloning and expression of recombinant
fragments of PVL subunits, along with the addition of synthetic
peptides indicated that the processed LukS-PV signal peptide,
which may act in conjunction with some other cell-wall
components, was sufficient to significantly enhance the ability of
S. aureus to attach to ECM components. Site directed mutagenesis
studies of the LukS-PV signal peptide together with the
biochemical analyses of the corresponding synthetic peptide
supports the following model: after its cleavage by signal peptidase,
the signal peptide is released from the membrane and binds to the
cell wall through its unique C-terminus sequence (TSFHESKA),
while its highly positively charged N-terminus binds to extracel-
lular matrix-associated heparan sulfates. These events would result
in a molecular bridge involving the signal peptide and heparan
sulfates that would allow the bacteria to attach to the host tissue.
Small peptides are widely used for bacterial communication
systems in Gram-positive bacteria [14] but the post-secretory
function of signal peptides has not been extensively characterized
in prokaryotes. For instance, the Staphylococcus haemolyticus
hemolysin H7 is made of three 44-amino-acid peptides, each
having a structure that resembles a signal peptide, suggesting
that these peptides are signal sequences from secreted or
membrane-associated proteins [15]. More recently, Firth et al.
described a lipoprotein signal peptide encoded by the staphylo-
coccal conjugative plasmid pSK41 exhibiting an activity resem-
bling that of Enterococcus faecalis pheromone cAD1, which induces
clumping of bacterial cells [16]. In contrast, eukaryote signal
peptides have been shown as good candidates for additional
functions beyond protein targeting to translocon [17]. For
instance, the HLA-E epitopes generated from the signal sequence
of the polymorphic MHC class I molecule, are further processed
and loaded to a non-polymorphic MHC class I molecule HLA-E,
generating a complex that is subsequently transported to the cell
surface for presentation to natural killer cells [18]. Another
example of the multiple functions of signal peptides is the fate of
signal peptide fragments of HIV-1 gp160 and of the human
preprolactin, which interfere with cytosolic calmodulin, a major
protein involved in the regulation of calcium metabolism
[17,19,20]. As stated by Martoglio, ‘‘there are almost undoubtedly
other components that interact with signal peptide fragments in
the cytosol or the extracellular space that are yet to be discovered’’
[20]. Despite fundamental differences in cell biology, prokaryote
and eukaryote signal peptides harbor similar structure and basic
functions, ensuring the proper targeting to the translocation
machinery; therefore, the discovery of post-secretory functions for
bacterial signal peptides should be expected. In bacteria, nascent
precursor proteins associated to ribosomes are targeted to the
translocation machinery to cross the membrane. They are then
released from the signal peptide by signal peptidase and the
Figure 11. Far-UV circular dichroism (CD) analyses of synthetic peptides LukS-PV SP (A) and LukF-PV SP (B) in various
environments. CD spectra were recorded in water (H2O), complemented with either 50% 2,2,2-trifluoroethanol (TFE) or 1% L-a-lysophosphatidyl
choline (LPC), or the following detergents: 100 mM sodium dodecyl sulfate (SDS), 100 mM n-dodecyl-b-D-maltoside (DM), or 100 mM dodecyl
phosphocholine (DPC).
doi:10.1371/journal.pone.0005042.g011
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remaining signal peptide is generally believed to be degraded by
membrane proteases. However, the fate of the signal peptide after
processing has not been elucidated [21].
Typical signal peptides are short sequences of 15 to 30 amino
acids composed of an N-terminal region (n-domain) including
positively charged residues, a hydrophobic core region (h-domain)
forming an a-helix, and a more polar, flexible region (c-domain)
containing the signal peptidase cleavage site [22]. Despite these
common features, experimental analyses of isolated signal peptides
revealed various conformational features, as both a-helical and ß-
sheet structures have been observed in different media ([23] and
references therein). It is thus reasonable to postulate that after the
signal peptidase cleavage, the fate of the released signal peptide is
likely dependent on their physico-chemical properties. In contrast
to the LukF-PV signal peptide, which is poorly soluble and
aggregates in water, the LukS-PV signal peptide was shown here
to be unfolded and soluble in water, and to exhibit limited
lipotrophic properties. These physico-chemical features suggest
that after its cleavage, the LukS-PV signal peptide could readily be
released from the membrane translocon context to the cytosolic or
extracellular aqueous environment. We thus hypothesized that at
least some residues of this signal peptide bind either to the cell wall
peptidoglycan or to its decorations, which include teichoic acids,
polysaccharides and proteins, and modify the adhesive capacity of
S. aureus. This is supported by the fact that the synthetic LukS-PV
signal peptide, but not the scrambled synthetic peptide, when
added externally to the bacteria, partially enhanced the adhesion
property of LUG960. Similarly, the 2% SDS supernatant obtained
from limited cell-surface extraction of the LukS-PV signal peptide
positive strain was able to enhance the adhesive properties of
LUG960. In contrast, cell-surface extracts prepared with mild
detergents such as DM or DPC were not as efficient to transfer the
adhesive capacity, suggesting that the LukS-PV signal peptide
strongly binds to the cell wall. Indeed, the LukS-PV signal peptide
was detected by western blot (using anti-histidine antibody) in the
2% SDS limited cell-surface extraction of the LukS-PV signal
peptide positive strain (Figure 9). It is thus speculated that LukS-
PV signal peptide behaves like Eap (extracellular adherence
protein, also known as Map and p70), an adhesin with broad
binding specificity but with particular affinity for the extracellular
matrix and plasma proteins, which binds to the S. aureus cell wall
by a sortase-independent mechanism. After translocation through
the cytoplasmic membrane and even after being released into the
extracellular space, Eap can re-associate to the S. aureus cell surface
by means of several Eap-binding structures including the teichoic
acids [24]. However, the limited efficiency of the synthetic signal
peptide to confer increased adhesion in comparison to that
produced in vivo, suggests that the peptide might act in conjunction
with some other cell-wall components; moreover one cannot
exclude that some post-translational modification of the signal
peptide could occur in the physiological situation.
Mutagenesis of LukS-PV signal peptide and chimeras combin-
ing fragments of LukS-PV and LukE signal peptide lead to the
hypothesis that the TSFHESKA sequence in the C-terminal half
of LukS-PV-signal peptide is essential for association to the
bacterial cell wall. Of note is that this sequence is unique to LukS-
PV signal peptide and has no homology to any reported sequence
in GeneBank. The cell wall determinant to which the LukS-PV
Figure 12. Identification of LukS-PV signal peptide residues involved in the adhesion phenotype using mutagenesis. Sequences of
wild type LukS-PV signal peptide (top) and mutants are shown on the left side, together with the alignment of sequences of LukE, LukF-PV and LukD
signal peptides (bottom). The binding capacity of the corresponding sequences to type IV collagen (5 mg/mL, Sigma) is shown on the right side.
Mutated amino acids are colored red while other LukS-PV SP amino acids are represented by dots. Deletion mutants of LukS-PV SP are denoted by
their sequence length (1–25 and 1–22).
doi:10.1371/journal.pone.0005042.g012
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signal peptide binds to remains to be determined. The fact that
Lactococcus lactis expressing LukS-PV signal peptide showed
enhanced adhesion suggests that the signal peptide-binding
determinant could be likely the N-acetylglucosamine moiety or
the wall-associated polymers, common features of Gram-positive
bacteria. An alternative model to explain the enhanced attach-
ment observed both when the LukS-PV signal peptide is produced
by the Staphylococcus or when added externally, is that the signal
peptide may bind and activate a surface receptor (such as a
membrane histidine protein kinase) or, because of its small size and
solubility it may diffuse in the cytosol, binds its cognate receptor
and modulates (at the level of transcription or translation) the
expression of proteins involved in adhesion. This model is in
keeping with the extended properties of Gram-positive bacteria,
which use small peptides as mating pheromones and quorum-
sensing signals in bacterial communication systems [14]. Again,
the fact that Lactococcus lactis strain expressing LukS-PV signal
peptide displays enhanced attachment to ECM proteins renders
the ‘‘signaling hypothesis’’ less likely and argues for a direct local
effect on the cell surface.
Whatever the mechanism involved, the described binding
features of the LukS-PV signal peptide to ECM components is
not a general property of all other S. aureus signal peptides: the
strains expressing LukF-PV signal peptide, TSST-1 signal peptide,
LukD signal peptide and LukE signal peptide did not induce an
enhanced adhesion phenotype. Both the mutagenesis experiments
and the use of chimeric constructs reveal the strict requirement of
three positives charges in the N-terminus for heparan sulfates
binding to occur. The KKR N-terminal basic cluster of LukS-PV
signal peptide constitutes a good candidate for heparan sulfates
binding site [25]. Heparin and heparan sulfates belong to the
family of glycosaminoglycans (GAGs) that consist in linear
polysaccharides occurring in all animal cell surfaces and in the
surrounding extracellular matrix generally as heparan sulfate
proteoglycans [26]. The heparan sulfate glycosaminoglycans bind
numerous adhesive and signaling molecules (cytokines, chemo-
kines, growth factors, extracellular matrix proteins) thus working
as a dynamic interface between the cells and the extracellular
space [27,28]. In addition, heparan sulfates bind efficiently to
various extracellular matrix proteins and play an important role in
mediating molecular bridges between the ECM proteins and
between cells and ECM proteins through their heparin binding
sites. This explains why purified ECM proteins may contain
residual amounts of heparan sulfate chains as suggested by our
data when using ECM proteins from commercial sources (Sigma-
Aldrich Technical Service confirmed that they cannot guarantee
the lack of residual heparan sulfates in their purified matrix protein
preparations). This observation does not contradict the fact that S.
aureus possesses specific and well characterized adhesins for ECM
proteins [29]. But the fact that heparan sulfates, which are also
highly abundant at the surface of respiratory epithelium, are the
ligand of the LukS-PV signal peptide, fits well with the current
model of necrotizing pneumonia [3,5,7] in which increased
bacterial adhesion to the surface of the epithelium promotes
bacterial infection. Note that other toxins from S. aureus also
appear to target heparan sulfates of epithelial cells as beta-toxin
increases the shedding of syndecan-1 (a major heparan sulfate
proteoglycan), and syndecan-1 null mice are significantly protected
from beta-toxin-induced lung injury [30].
Altogether, the present study provides new insights into the
potential of signal peptides to contribute to other functions beyond
protein secretion and propose an original mechanistic explanation
of the enhanced adhesion of PVL positive strains to various ECM
components.
Materials and Methods
Strains and growth conditions
Escherichia coli DH5a (Stratagene) and S. aureus RN4220, a
nitrosoguanidine-induced mutant capable of accepting E. coli
DNA [31], were used for plasmid amplification and genetic
manipulations. S. aureus RN6390 derives from 8325-4 and is an
standard agr+ strain. The phiSLTstrain (LUG855) was obtained by
lysogenization of RN6390 with phiSLT phage carrying luk-PV
[7,32]. The phiSLTDPVL strain (LUG776) is the partial deletion
Dpvl ::tetM mutant of S. aureus LUG855. In this strain, the PVL
operon was not totally deleted; the first 41 amino acids LukS-PV
and the last 128 amino acids of LukF-PV remained [32]. S. aureus
strains LAC (USA300), LACDPVL, MW2 (USA400) and
MW2DPVL were constructed and generously provided by Dr.
Frank DeLeo. Clinical1 is a luk-PV negative clinical strain from
gut; clinical1phiSLT is clinical1 lysogenized with phiSLT; clinical2
is a luk-PV negative clinical strain from a furuncle; clinical2-
phiSLT is clinical2 lysogenized with phiSLT; clinical3 is a luk-PV
negative clinical strain from pneumonia; clinical3phiSLT is
clinical3 lysogenized with phiSLT. Lactococcus lactis subsp. cremoris
1363 and its derivative carrying a Luk-PV plasmid were
generously provided by Dr Philippe Moreillon and Mathilde
Ythier. The Luk-PV plasmid was made by insertion of the luk-PV
operon onto the L. lactis vector pOri23 [33]. LukS-PV, LukS-PV
signal peptide and LukE signal peptide were amplified and cloned
on pOri 23 (Tables 1 and 2).
Staphylococci were grown either on BM agar plates (1% peptone,
0.5% yeast extract, 0.1% glucose, 0.5% NaCl, 0.1% K2HPO4), or
in brain-heart infusion (BHI), with chloramphenicol (20 mg/ml) or
erythomycin (5 mg/ml) when appropriate. L. lactis cremoris was
grown at 30uC in M17 medium (Oxoid) supplemented with 0.5%
glucose [33].
DNA manipulation and genetic constructions
Total DNA and plasmid DNA were prepared with standard
methods [34]. Transformation of Escherichia coli DH5a and M15
was performed by treatment with CaCl2, and S. aureus strains were
transformed by electroporation (Bio-Rad gene pulser).
Lysogenization was performed using 50 ml of phiSLT phage
carrying luk-PV (1011–1012 UFP/ml) [32]. The deletion/replace-
ment Dspa::kana mutant of S. aureus RN6390 and LUG776 were
obtained by using pMAD, a thermosensitive plasmid which
contains a constitutively expressed ß-galactosidase gene that allows
positive selection of double cross-overs by screening the ß-
galactosidase activity on X-gal agar plates [35]. A 1 kbp DNA
fragment corresponding to the kanamycin resistance gene was
amplified from pCR2.1TM plasmid (Invitrogen) using primers
kcr5/kcr6 and cloned between two DNA fragments corresponding
to the flanking regions of protein A gene (spa) generated using
oligonucleotides spa28/spa692 (664 pb) and spa2014/spa 2510
(496 pb), in pMAD. The resulting plasmid, pLUG196, was
electroporated into RN4220, and then into RN6390 and
LUG776. Transformants were grown at the non-permissive
temperature (37uC), to select for cells in which the plasmid had
been integrated into the chromosome by homologous recombina-
tion. To favor the second recombination event, a single colony was
grown at 30uC for 10 generations and plated at 37uC overnight.
Cells, which have lost the plasmid vector through a double
crossing over event, were detected on Xgal agar plates. PCR
amplifications were used to confirm the loss of most of the spa
gene, which was replaced by the kanamycin resistance gene. The
resulting strains were designated LUG960 and LUG1500
(Table 1).
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The luk-PV genes were expressed in Staphylococcus RN6390 or
LUG960 by using plasmid pSK265, which is a derivative of
pC194 with a pUC18 polylinker region inserted at its unique
HindIII site [36]. All cloning were first made in E. coli on
pBluescriptTM vector (Stratagene), verified by sequencing and
subcloned onto pSK265 restricted by XbaI and KpnI. The luk-PV
operon (including promoter and transcriptional terminator) was
amplified using primers phi262 and phi2815. The 39 regions of the
luk-PV operon, were first cloned on a plasmid that contained the
P-luk-PV promoter region (amplified using primers phi262/
phi758) and the 59 regions, on a plasmid that contained the luk-
PV transcriptional terminator (amplified using primers phi2648/
phi2815). In order to express intramolecular sequences of luk-PV
or signal peptides, the promoter and terminator regions were
Table 1. Strains.
S. aureus strains Relevant characteristics Name used in text Reference or source
8325-4 NCTC8325 cured of three prophages [44]
RN4220 restriction-mutant of 8325-4 [31]
RN6390 derivative of 8325-4, agr positive [45]
LUG855 RN6390phiSLT RN6390phiSLT [7,32]
LUG776 LUG855 partial DPVL::tmn
LUG960 RN6390Dspa::kana parental This work
LUG1500 LUG776Dspa::kana chromosomal partial DPVL This work
LUG1501 LUG960/pLUG534 Luk-PV plasmid This work
LUG1137 LUG960/pLUG549 41aa Nterm LukS-PV This work
LUG1155 LUG960/pLUG560 no insert plasmid This work
LUG1157 LUG960/pLUG652 128aa Cterm LukF-PV This work
LUG1159 LUG960/pLUG654 LukS-PV SP This work
LUG1198 LUG960/pLUG670 LukS-PV DSP This work
LUG1211 LUG960/pLUG676 TSST-1 SP This work
LUG1225 LUG960/pLUG671 LukF-PV SP This work
LUG1237 LUG960/pLUG725 LukF-PV plasmid This work
LUG1238 LUG960/pLUG726 LukS-PV plasmid This work
LUG1509 LUG960/pLUG732 LukE-SP This work
LUG1510 LUG960/pLUG733 LukD-SP This work
LUG1502 LUG960/ pLUG737 luk-PV mRNA This work
LUG1503 LUG960/pLUG755 R5K This work
LUG1504 LUG960/pLUG760 H24Q This work
LUG1417 LUG960/pLUG774 H24A This work
LUG1419 LUG960/pLUG775 S22P This work
LUG1422 LUG960/pLUG776 1–25 This work
LUG1428 LUG960/pLUG777 1–22 This work
LUG1431 LUG960/pLUG778 K27A This work
LUG1461 LUG960/pLUG786 K4N This work
LUG1463 LUG960/pLUG787 K4N/K5A This work
LUG1465 LUG960/pLUG788 K3A/K4N This work
LUG1487 LUG960/pLUG797 LukS::LukE This work
LUG1488 LUG960/pLUG798 E25Q This work
LUG1493 LUG960/pLUG799 LukE::LukS This work
LUG1631 LUG960/pLUG907 K3A/K4N::LukS-PV This work
LUG1634 LUG960/pLUG908 His-LukS-PV This work
LUG1637 LUG960/pLUG910 LukE::LukS::LukS-PV This work
LUG1638 LUG960/pLUG911 K4N/K5A::LukS-PV This work
LUG1642 LUG960/pLUG912 His-LukS-PV SP This work
LUG1643 LUG960/pLUG913 LukS::LukE::LukS-PV This work
LUG1601 Lactococcus lactis 1363/pLUG886 L.lactis LukS-PV This work
LUG1602 Lactococcus lactis 1363/pLUG887 L.lactis LukE-PV SP This work
LUG1616 Lactococcus lactis 1363/pLUG888 L.lactis LukS-PV SP This work
doi:10.1371/journal.pone.0005042.t001
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cloned onto pSK265 separated by a short cloning sequence
containing the restriction sites EcoRV and BamHI (Tables 1 and 2).
Colorimetric adhesion assay to ECM components
Adherence to elastin from human lung (Sigma), type I, IV, V
collagen (Sigma) and laminin (Sigma) was performed in ninety-six–
well microtiter plates as described [5]. Preparation of purified
collagens I and V from distinct sources have been performed in
our laboratory. Collagen I was extracted by pepsin digestion in
0.5 M acetic acid, 0.2 M NaCl at 4uC for 20 hours from bovine
fetal bones and was subsequently purified by repeated salt-
fractionation as described [37] and recombinant V produced in
human embryonic kidney cell line (293-HEK) cells and purified as
described previously [38].
To test the effect of heparin/heparan sulfates on adhesion,
increasing concentrations of heparin (Sigma) or heparan sulfates
(Sigma) were added to the bacterial suspension, and incubated for
30 min at 37uC. After treatment, the suspension was washed with
200 mL PBS 3 times and used in the adhesion assay.
To test the effect of digestion of ECM proteins with heparinase,
increasing concentrations of heparinase III (Sigma) were added to
laminin, elastin and type V, IV, I collagens (Sigma) coated wells,
and incubated for 1 h at room temperature. After treatment, the
wells were washed with 200 mL PBS 3 times, blocked with 200 mL
Table 2. Plasmids.
Staphylococcal plasmids
pC194 3 kb S. aureus plasmid, inducible chloramphenicol resistance (cat) [46]
pSK265 pC194::pUC19 MCS [36]
pLUG534 pSK265::luk-PV This work
pLUG549 pSK265::Nter LukS-PV (41aa) This work
pLUG560 pSK265::P-luk-PV–TT-luk-PV (PVL vector) This work
pLUG652 pSK265::Cter LukF-PV (128aa) This work
pLUG654 pSK265::LukS-PV signal peptide This work
pLUG670 pSK265::LukS-PVD signal peptide This work
pLUG671 pSK265::LukF-PV signal peptide This work
pLUG676 pSK265::TSST-1 signal peptide This work
pLUG725 pSK265::lukF-PV This work
pLUG726 pSK265::lukS-PV This work
pLUG732 pSK265::LukE signal peptide This work
pLUG733 pSK265::LukD signal peptide This work
pLUG737 pSK265::luk-PV mRNA This work
pLUG755 pSK265::mutated LukS-PV signal peptide: R5K This work
pLUG760 pSK265::mutated LukS-PV signal peptide: H24Q This work
pLUG774 pSK265::mutated LukS-PV signal peptide: H24A This work
pLUG775 pSK265::mutated LukS-PV signal peptide: S22P This work
pLUG776 pSK265::shortened LukS-PV signal peptide: [1–25] This work
pLUG777 pSK265::shortened LukS-PV signal peptide: [1–22] This work
pLUG778 pSK265::mutated LukS-PV signal peptide: K27A This work
pLUG786 pSK265::mutated LukS-PV signal peptide: K4N This work
pLUG787 pSK265::mutated LukS-PV signal peptide: K4N/K5A This work
pLUG788 pSK265::mutated LukS-PV signal peptide: K3A/K4N This work
pLUG797 pSK265::chimeric signal peptide: LukS-PV [aa 1–20]::LukE [aa 21–28] This work
pLUG798 pSK265::mutated LukS-PV signal peptide: E25Q This work
pLUG799 pSK265::chimeric signal peptide: LukE [aa 1–20]::LukS-PV [aa 21–28] This work
pLUG886 pORI23::LukS-PV signal peptide This work
pLUG887 pORI23::LukE signal peptide This work
pLUG888 pORI23::LukS-PV This work
pLUG907 pSK265::mutated LukS-PV signal peptide K3A/K4N::LukS-PV This work
pLUG908 pSK265::6xHis::LukS-PV This work
pLUG910 pSK265::chimeric signal peptide: LukE [aa 1–20]::LukS-PV [aa 21–28]::LukS-PV This work
pLUG911 pSK265::mutated LukS-PV signal peptide K4N/K5A::LukS-PV This work
pLUG912 pSK265::6xHis::LukS-PV signal peptide This work
pLUG913 pSK265::chimeric signal peptide: LukS-PV [aa 1–20]::LukE [aa 21–28]::LukS-PV This work
doi:10.1371/journal.pone.0005042.t002
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of 0.2% BSA in PBS at 4uC for 2 h, and used in the adhesion
assay.
To analyze whether the adhesive properties of LukS-PV signal
peptide-expressing bacteria could be mediated by cell wall
associated material, a brief 2% SDS or DPC or DM cell extract
was prepared as follows: following culture and centrifugation, the
bacterial pellet of the donor strain was resuspended in 1 mL
extraction buffer (10 mM Tris-HCl pH 7.0, 2% SDS or DPC or
DM), heated at 95uC for 2 min, and then centrifuged at 13,0006g
for 10 min [39]. The supernatant (pure or diluted in PBS) was
used to resuspend the bacterial pellet of the recipient strain to be
tested in the adhesion assay to ECM proteins.
Synthetic signal peptide of LukS-PV (MVKKRLLAATLSL-
GIITPIATSFHESKA), LukF-PV (MKKIVKSSVVTSIALLLL-
SNTVDA) and scrambled peptide of LukS-PV signal peptide
(PGAVHIKSIKTRIELMSLAKLTSAFTAL), were synthesized
in-house (by S. Gurussiddappa) and tested for complementation
of LUG960 cells in the adhesion assay. Synthetic peptides were
added to the bacterial suspension (100 mL/ well; 109 CFU/mL in
PBS) at 0.5 to 1000 mg/mL final concentration and the mixture
was loaded into the microtiter plates containing ECM components
as described [5]. Alternatively, synthetic peptide was added to non
adherent bacterial cells and the mixture was subjected to 2% SDS
extraction as described above. The resulting extract was used to
resuspend the bacterial pellet of the recipient strain to be tested in
the adhesion assay to ECM proteins.
Quantification of Panton Valentine Leukocidin
production by ELISA
The level of PVL production in the supernatant after 24 h of
staphylococcal culture was determined in duplicate by using an
ELISA method as described previously [40].
Surface plasmon resonance based binding assay
A BIAcore 3000 system, CM4 sensor chip, amine coupling kit
and HBS-P buffer (10 mM HEPES, 150 mM NaCl, 3 mM
EDTA, 0.005% surfactant P20, pH 7.4) were from Biacore AB.,
Heparan sulfate was from Celsus, streptavidin from sigma and
biotin-hydrazine from Pierce. Heparan sulfate (HS) was biotiny-
lated at its reducing end as described [41], and immobilized on a
streptavidin activated sensorchip. For this purpose, 0.2 M of N-
ethyl-N9-(diethylaminopropyl)-carbodiimide (EDC) and 0.05 M of
N-hydroxysuccinimide (NHS), were injected for ten minutes over
two flow cells of a CM4 sensorchip after which streptavidin at
0.2 mg/ml in 10 mM sodium acetate buffer, pH 4.2, was injected
for a further ten minutes. Remaining activated groups were
blocked with 1 M ethanolamine, pH 8.5. Typically, this procedure
allowed the coupling of 3000–3500 resonance units (RU) of
streptavidin on both flow cells. Biotinylated HS (100 mg/ml) was
then captured to a level of 250 RU on one surface, the other one
being left untreated to served as negative control. For binding
assays, LukS-PV signal peptide in HBS-P was simultaneously
injected over both negative control and HS surfaces for 5 min at
25uC and 50 ml/min. The HS surface was regenerated with a
250 ml pulse of 2 M NaCl. Control sensorgrams were subtracted
on line from HS sensorgrams, and the resulting binding curves
were analyzed using the Biaeval 3.1 software.
Circular dichroism (CD)
Far UV CD spectra were recorded on a Chirascan spectrometer
(Applied Photophysics, UK) calibrated with 1S-(+)-10-camphor-
sulfonic acid. Measurements were carried out at 298 K in a 0.1-cm
path length quartz cuvette (Hellma), with peptide concentrations
ranging from 58 to 150 mM. Spectra were measured in a 180 nm
to 260 nm wavelength range with a increment of 0.2 nm,
bandpass of 0.5 nm and integration time of 1 s. Spectra were
processed, baseline corrected, smoothed and converted with the
Chirascan software. Secondary structure analysis was carried out
on the DICHROWEB server [42] using the CDSSTR program
[43]. CD experiments were performed on the platform ‘Produc-
tion et Analyse de Prote´ines’ from the IFR 128 BioSciences
Gerland - Lyon Sud.
Supporting Information
Figure S1 Inhibition of adhesion to ECM components by
heparan sulfates Isogenic strains of Staphylococcus aureus
examined for their binding capacity to the indicated ECM
proteins (Y-axis, absorbance reading at 540 nm) coated on 96-well
plates, at concentrations of 5 mg/mL (collagen I-panel A, collagen
V-panel B, elastin-panel C, laminin-panel D). Heparan sulfates
were added at decreasing concentrations (X-axis) to the bacteria
before the adhesion assay. Parental (LUG960) indicates the genetic
background in which the genetic modifications were made; LukS-
PV SP, parental carrying a plasmid encoding the LukS-PV signal
peptide. The vertical lines indicate the standard deviations.
Found at: doi:10.1371/journal.pone.0005042.s001 (2.44 MB TIF)
Table S1 Quantification of Panton Valentine Leukocidin
production by ELISA
Found at: doi:10.1371/journal.pone.0005042.s002 (0.03 MB
DOC)
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